Gastroprotective Activity of the Novel Proton Pump Inhibitor Lansoprazole in the Rat

Author： Morini G.   Grandi D.   Arcari M.L.   Bertaccini G.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.26, Iss.5, 1995-09, pp. : 1021-1025

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats

By Kinoshita M.   Saito N.   Tamaki H.  

European Journal of Pharmacology, Vol. 321, Iss. 3, 1997-03 ,pp. : 325-332

Elsevier

Access to resources Recommend Favorite

Involvement of Da1 and Da2 Receptors in the Gastroprotective Activity of Amylin in the Rat

By Clementi G.   Caruso A.   Cutuli V.M.A.R.I.A.C.A.T.E.N.A.   de Bernardis E.   Prato A.   Amico-Roxas M.  

Pharmacological Research, Vol. 38, Iss. 3, 1998-01 ,pp. : 221-224

Academic Press

Access to resources Recommend Favorite

Pattern of Proton Pump Inhibitor Calls to Texas Poison Centers, 1998-2004

By Forrester Mathias  

Journal of Toxicology and Environmental Health, Vol. 70, Iss. 8, 2007-01 ,pp. : 705-714

Taylor & Francis Ltd

Access to resources Recommend Favorite

Genetics of Response to Proton Pump Inhibitor Therapy: Clinical Implications

By Dickson E.J.   Stuart R.C.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 5, 2003-01 ,pp. : 303-315

Adis International

Access to resources Recommend Favorite

Indications and safety of proton pump inhibitor drug use in patients with cancer

By Triadafilopoulos George   Roorda Andrew K   Akiyama Junichi  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 659-672

Informa Healthcare

Access to resources Recommend Favorite